Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by a heterozygous variant in the IMPG2 gene.
No clinical trials have been registered for IMPG2-related dominant retinopathy.
3 publications have been identified in PubMed for IMPG2-related dominant retinopathy. Research spans Case Report / Case Series (67%) and Epidemiology / Natural History (33%).
Elsayed MEAA (2026). [PMID: 41495677](https://pubmed.ncbi.nlm.nih.gov/41495677/). *BMC Ophthalmol*. [Case Report / Case Series]
Amato A (2025). [PMID: 40236509](https://pubmed.ncbi.nlm.nih.gov/40236509/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Seddon JM (2024). [PMID: 39693084](https://pubmed.ncbi.nlm.nih.gov/39693084/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 11:36 PM UTC
Common questions about IMPG2-related dominant retinopathy